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Conclusion: HDR-BT seems to be a good alternative for 
treatment of epitheliomas in special locations, above all in 
elderly patients with comorbidities that preclude surgery. Its 
ability to treat a wide area with minimal alteration of normal 
tissues allows a high probability of cure with excellent 
cosmetic results and without affecting functionality.  
We can conclude that HDR-BT could be a valid alternative to 
surgery with acceptable acute toxicity, good early local 
control and exceptional cosmetic outcomes in skin lesions. 
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Purpose or Objective: Rhabdomyosarcoma of the vagina is 
very rare disease, mainly girls were 1-3 years, only a few 
patients were 13-15 years old. Early studies have shown the 
advantage of intracavitary radiation therapy over surgical 
treatment and EBRT. There are new methods of planning 
EBRT from CRT moved to VMAT and IMRT. The emergence of 
new techniques in the EBRT and brachytherapy inspired us to 
the evaluation of methods of treatment children's vaginal 
rhabdomyosarcoma. 
 
Material and Methods: From 1980 till 2015 38 patients 
received intracavitary brachytherapy with source Co-60 and 
Ir-192. In our cancer center were made special applicators of 
different designs. The main treatments were applicators for 
direct 8 mm diameter and a length of about 6-7 cm. Were 
specially made Co-60 tube source (LDR). Children were 
immobilized for several days. The active length was 4-5 cm.  
Since the 90s we switched to using stepping source Ir-192 
HDR. Normalisation point changed from 5 mm to 2 mm from 
the surface of applicator.This made it possible to irradiate 
the entire vagina. 
Planning is optimized for the creation of uniform dose 
distribution throughout the vagina. Accordingly, it was 
necessary to calculate dose distribution for these cases. For 
calculations were chosen CT and MRI and patient anatomy 
was extended, contoured target and OAR's. The calculation of 
CRT / IMRT / VMAT / Brachy. CTV was 6.5 cm3. 
Unlike cervical cancer, in OAR's we added the urethra, which 
is located close to vagina, and which dose close to 100%. We 
have calculated % dose to the rectum, bladder, urethra and 
ovaries. For EBRT, we calculated the mean dose to OAR's, 
Brachytherapy for rectum and bladder, we calculated dose to 
1 cm3, and the entire volume of urethra and ovaries. 
 
Results: In both cases (EBRT and Brachy) ovaries was about 
2% (2.0% -2.3%) of normalisation dose. However, it is worth 
considering that brachytherapy is given high dose per 
fraction, so radiobiological dose above.  
CRT / IMRT / VMAT / Brachy:  
Rectum: 37.7 / 26.6 / 29.9 / 37.2 % 
Bladder: 58.7 / 39.6 / 37.1 / 30.8 % 
Uretra: 99.0 / 99.2 / 97.2 / 50.2 % 
 
Conclusion: Although improvement in EBRT (from CRT to 
IMRT and VMAT) and decrease in dose to OAR's, 
brachytherapy maintains its position in the treatment of this 
localization. When less integral dose brachytherapy and dose 
on OAR's (not whole body is irradiated, but only part of it), 
which significantly reduces late effects. In modern time, we 
should pay attention to other radionuclides, which can give 
uniform dose distribution (example Yb-169). 
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Purpose or Objective: To characterize PD-L1 expression in 
non-small-cell lung cancer (NSCLC) cell lines, and explore the 
relationship between immunology escaping and tumor cell 
proliferlation and apoptosis with receiving radiotherapy. 
 
Material and Methods: Evaluating the PD-L1 protein and 
CD8+ T cells with immunohistochemistry in tumor tissue from 
NSCLC patients. In vitro assay, to detect the expression of 
PD-L1 in different NSCLC cell lines after conventional and 
hypofractionated radiation therapy by westernbloting and 
study the difference between A549 and radiation resistance 
A549 cell line by flow cytometry and westernbloting. To 
analysis PI3K/Akt and stat3 proliferation pathway and Bcl2 
family apoptosis signaling pathway in A549 radiation 
resistance cell by westernbloting. Small interfering RNA 
(siRNA) was used to A549 radiation resistance cell, and then 
to observe the difference in PI3K/Akt and stat3 pathway. As 
for in vivo study, immunohistochemistry was used to detect 
the relationship between the expression of PD-L1 and NF-KB 
protein in control group, anti-PD-L1 group, radiation group 
and radiation plus anti-PD-L1 group. 
 
Results: We found that patients whose tumor expression the 
higher PD-L1 protein, who had the more radiation resistance 
and had less CD8+ T cell around tumor microenvironment. 
PD-L1 protein improved obviously in NSCLC cell lines after 
receiving conventional radiation, but there is not the same 
tendency after hypofractionated radiation. We found that 
A549 radiation resistance cell had activation in PI3K/Akt and 
stat3 pathway and its’ NF-KB protein would be up-regulation. 
When the A549 acquired radiation resistance, it would be 
apoptotic less. We observed the activation of the anti-
apoptosis protein bcl2 and the inhibition of the pro-apoptosis 
protein bim in A549 radiation resistance cell. After siRNA 
interfering to this cell, it’s PD-L1 protein decreased. A549 
radiation resistance cell came to be apoptosic. While it’s 
pAkt, pstat3 and NF-KB didn’t change. 
 
Conclusion: Conventional radiation would be easy to induce 
radiation resistance by overexpressing the PD-L1. When the 
lung cancer cell express PD-L1 more, the tumor would escape 
from CD8+ T cell. NF-KB protein is the key to up-regulation 
PD-L1. When PD-L1 overexpression, lung cancer would be 
apoptosis less and immunity escaping. SiRNA interfering PD-
L1 can eliminate the radiation resistance of the A549 cell 
line. It provide the evidence for the combination of the anti-
PD-L1 drug and radiation therapy in clinic. 
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